The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein
Open accessAbstract
We demonstrated the presence of two adeno-associated viruses (AAVs), designated AAV10 and AAV11, in cynomolgus monkeys by isolating and sequencing the entire viral coding regions from the monkey DNA. AAV10 and AAV11 capsid proteins shared 84% and 65%, respectively, of amino acids with AAV2. A phylogenetic analysis of AAV capsid proteins showed that AAV10 and AAV11 resembled most AAV8 and AAV4, respectively. To characterize the capsid protein, we pseudotyped an AAV2 vector with the monkey AAV capsid proteins and examined the resulting pseudotypes AAV2/10 and AAV2/11, in comparison with the AAV2 vector, for their host ranges in cell lines and tissue tropism in mice. AAV2/10 and AAV2/11 transduced primate cells less efficiently than AAV2. Whereas AAV2 transduced undifferentiated C2C12 mouse myoblasts more efficiently than differentiated ones, AAV2/10 and AAV2/11 transduced the undifferentiated myoblasts less efficiently than differentiated ones. Three weeks after injection to the muscle of the hind legs, AAV2/10 and AAV2 induced transgene expression similarly, but AAV2/11 did not transduce the skeletal muscle. Six weeks after systemic administration, transduced vector DNA was detected by PCR in the liver and spleen of mice inoculated with AAV2, in the liver, heart, muscle, lung, kidney, and uterus of mice with AAV2/10, and the muscle, kidney, spleen, lung, heart, and stomach of mice with AAV2/11. Mouse antisera against capsid protein VP2 of the three AAVs neutralized the respective vector particles in a type-specific manner. The results indicate that AAV10 and AAV11 capsid proteins, which are antigenically distinct from each other and AAV2, are likely to determine their host ranges and tissue tropism that are different from AAV2s, suggesting that cynomolgus AAVs could provide a broader choice of pseudotype AAV vectors for gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene therapy vectors based on adeno-associated virus type 1
Xiao, W., Chirmule, N., Berta, S. C., McCullough, B., Gao, G., & Wilson, J. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3994-4003.1999 · Cited by 541
Chao, H., Liu, Y., Rabinowitz, J., Li, C., Samulski, R. J., & Walsh, C. E. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0219 · Cited by 366
Research works printed but not linked: 17
- Atchison, 1965, Adenovirus-associated defective virus particles, Science, 149, 754, 10.1126/science.149.3685.754 · DOI · Paper page
- Bantel-Schaal, 1984, Characterization of the DNA of a defective human parvovirus isolated from a genital site, Virology, 134, 52, 10.1016/0042-6822(84)90271-X · DOI · Paper page
- Blau, 1983, Cytoplasmic activation of human nuclear genes in stable heterocaryons, Cell, 32, 1171, 10.1016/0092-8674(83)90300-8 · DOI · Paper page
- Duan, 2001, Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 correlates with myoblast differentiation, J. Virol., 75, 7662, 10.1128/JVI.75.16.7662-7671.2001 · DOI
- Gao, 2002, Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy, Proc. Natl. Acad. Sci. U.S.A., 99, 11854, 10.1073/pnas.182412299 · DOI · Paper page
- Gao, 2003, Adeno-associated viruses undergo substantial evolution in primates during natural infections, Proc. Natl. Acad. Sci. U.S.A., 100, 6081, 10.1073/pnas.0937739100 · DOI · Paper page
- Gao, 2004, Clades of adeno-associated viruses are widely disseminated in human tissues, J. Virol., 78, 6381, 10.1128/JVI.78.12.6381-6388.2004 · DOI · Paper page
- Georg-Fries, 1984, Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus, Virology, 134, 64, 10.1016/0042-6822(84)90272-1 · DOI · Paper page
- Grimm, 2003, From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy, Curr. Gene Ther., 3, 281, 10.2174/1566523034578285 · DOI · Paper page
- Hildinger, 2001, Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer, J. Virol., 75, 6199, 10.1128/JVI.75.13.6199-6203.2001 · DOI · Paper page
- Hoggan, 1966, Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics, Proc. Natl. Acad. Sci. U.S.A., 55, 1467, 10.1073/pnas.55.6.1467 · DOI · Paper page
- Melnick, 1965, Association of 20 millimicron particles with adenoviruses, J. Bacteriol., 90, 271, 10.1128/jb.90.1.271-274.1965 · DOI
- Mori, 2002, Rescue of AAV by antibody-induced Fas-mediated apoptosis from viral DNA integrated in HeLa chromosome, Virology, 301, 90, 10.1006/viro.2002.1579 · DOI
- Muzyczka, 2001, Parvoviridae: the viruses and their replication, vol. 2, 2327
- Walters, 2002, Secreted and transmembrane mucins inhibit gene transfer with AAV4 more efficiently than AAV5, J. Biol. Chem., 277, 23709, 10.1074/jbc.M200292200 · DOI
- Rabinowitz, 2002, Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity, J. Virol., 76, 791, 10.1128/JVI.76.2.791-801.2002 · DOI · Paper page
- Xiao, 1998, Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus, J. Virol., 72, 2224, 10.1128/JVI.72.3.2224-2232.1998 · DOI · Paper page
Cited by
Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses
Calcedo, R., Vandenberghe, L. H., Gao, G., Lin, J., & Wilson, J. M. (2009) · The Journal of Infectious Diseases · doi:10.1086/595830 · Cited by 808
High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors
Petrs-Silva, H., Dinculescu, A., Li, Q., Min, S.-H., Chiodo, V., Pang, J.-J., Zhong, L., Zolotukhin, S., Srivastava, A., Lewin, A. S., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2008.269 · Cited by 398
Current approaches to enhance CNS delivery of drugs across the brain barriers
Lu, C.-T., Zhao, Y.-Z., Wong, H. L., Cai, J., Peng, L., & Tian, X.-Q. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s61288 · Cited by 350
Capsid modifications for targeting and improving the efficacy of AAV vectors
Büning, H., & Srivastava, A. (2019) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2019.01.008 · Cited by 260
Intracellular trafficking of adeno-associated viral vectors
Ding, W., Zhang, L., Yan, Z., & Engelhardt, J. F. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302527 · Cited by 251
Metadata
- Authors
- Mori, S., Wang, L., Takeuchi, T., & Kanda, T.
- Venue
- Virology
- Publisher
- Elsevier BV
- Published
- 2004-12
- Volume
- 330
- Issue
- 2
- Pages
- 375-383
- ISSN
- 0042-6822 (ISSN-L)
- OpenAlex
- W2033530205
- Cited by
- 245
- References
- 2
- FWCI
- 9.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3186 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein. https://app.cochat.ai/papers/10.1016/j.virol.2004.10.012
- The paper
- Mori, S., Wang, L., Takeuchi, T., & Kanda, T. (2004). Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein. Virology. https://doi.org/10.1016/j.virol.2004.10.012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.